Dr. Ignacio Bernabeu Morón, endocrino

Dr. Ignacio Bernabeu Morón, endocrino

citations

Pasa consulta en Santiago

  • Licenciado en Medicina y Cirugía por la Universidad Complutense de Madrid (1984).
  • Especialista en Endocrinología y Nutrición, Clínica Puerta de Hierro (Universidad Autónoma de Madrid) 1989.
  • Doctor en Medicina y Cirugía, Universidad de Santiago de Compostela (2010).
  • Profesor Asociado de Medicina de la USC.
  • Ejercicio profesional como Endocrinólogo desde 1990.
  • Actividad científica en http://scholar.google.es/citations?user=YuyH1pcAAAAJ.

 

ACTIVIDAD CIENTIFICA: Citado por Año
High prevalence of AIP gene mutations following focused screening in young patients with sporadic pituitary macroadenomas
MA Tichomirowa, A Barlier, AF Daly, ML Jaffrain-Rea, C Ronchi, …
European Journal of Endocrinology 165 (4), 509-515
45 2011
Coadministration of lanreotide Autogel and pegvisomant normalizes IGF1 levels and is well tolerated in patients with acromegaly partially controlled by somatostatin analogs alone
AJ van der Lely, I Bernabeu, J Cap, P Caron, A Colao, J Marek, …
European Journal of Endocrinology 164 (3), 325-333
22 2011
Genetic diagnosis of X-linked dominant Hypophosphatemic Rickets in a cohort study: tubular reabsorption of phosphate and 1, 25 (OH) 2D serum levels are associated with PHEX mutation type
M Morey, L Castro-Feijóo, J Barreiro, P Cabanas, M Pombo, M Gil, …
BMC medical genetics 12 (1), 116
19 2011
Pituitary stalk dysgenesis-induced hypopituitarism in adult patients: prevalence, evolution of hormone dysfunction and genetic analysis
E Fernandez-Rodriguez, C Quinteiro, J Barreiro, M Marazuela, I Pereiro, …
Neuroendocrinology 93 (3), 181-188
17 2011
Pegvisomant-induced liver injury is related to the UGT1A1* 28 polymorphism of Gilbert’s syndrome
I Bernabeu, M Marazuela, T Lucas, L Loidi, C Alvarez-Escolá, …
The Journal of Clinical Endocrinology & Metabolism 95 (5), 2147-2154
17 2010
Somatotroph tumor progression during pegvisomant therapy: a clinical and molecular study
M Marazuela, AE Paniagua, MD Gahete, T Lucas, C Alvarez-Escolá, …
The Journal of Clinical Endocrinology & Metabolism 96 (2), E251-E259
15 2010
Long-term treatment of acromegalic patients resistant to somatostatin analogues with the GH receptor antagonist pegvisomant: its efficacy in relation to gender and previous radiotherapy
M Marazuela, T Lucas, M Puig-Domingo, NG de la Torre, …
European Journal of Endocrinology 160 (4), 535-542
15 2009
The exon 3-deleted growth hormone receptor is associated with better response to pegvisomant therapy in acromegaly
I Bernabeu, C Alvarez-Escolá, C Quinteiro, T Lucas, M Puig-Domingo, …
The Journal of Clinical Endocrinology & Metabolism 95 (1), 222-229
13 2010
Anterior pituitary function in Cushing’s syndrome: study of 36 patients.
C Cuerda, J Estrada, M Marazuela, A Vicente, B Astigarraga, I Bernabeu, …
Endocrinologia japonica 38 (5), 559-563
12 1991
Pegvisomant and cabergoline combination therapy in acromegaly
I Bernabeu, AE Paniagua, T Lucas, I Pavón, FF Casanueva, M Marazuela
Pituitary 16 (1), 101-108
11 2013
Changes in acromegaly treatment over four decades in Spain: analysis of the Spanish Acromegaly Registry (REA)
G Sesmilo, S Gaztambide, E Venegas, A Picó, C Del Pozo, C Blanco, …
Pituitary 16 (1), 115-121
10 2013
Alvarez-Escolá C, Quinteiro C, Lucas T, Puig-Domingo M, Luque-Ramírez M, de Miguel-Novoa P, Fernandez-Rodriguez E, Halperin I, Loidi L, Casanueva FF, Marazuela M: The exon 3-deleted growth hormone receptor is associated with better response to pegvisomant therapy in acromegaly
I Bernabeu
J Clin Endocrinol Metabol 95 (1), 222-229
8 2010
Álvarez-Escolá C, Quinteiro C, Lucas T, Puig-Domingo M, Luque-Ramírez M, et al. The exon 3-deleted growth hormone receptor is associated with better response to pegvisomant therapy in acromegaly
I Bernabeu
J Clin Endocrinol Metab 95 (1), 222-9
6 2010
Epidemiology, mortality rate and survival in a homogeneous population of hypopituitary patients
E Fernandez‐Rodriguez, M Lopez‐Raton, P Andujar, IM Martinez‐Silva, …
Clinical endocrinology 78 (2), 278-284
5 2013
Subclinical hypopituitarism
E Fernandez-Rodriguez, I Bernabeu, P Andujar-Plata, FF Casanueva
Best Practice & Research Clinical Endocrinology & Metabolism 26 (4), 461-469
5 2012
Pegvisomant-induced cholestatic hepatitis with jaundice in a patient with Gilbert’s syndrome
I Bernabeu, J Cameselle-Teijeiro, FF Casanueva, M Marazuela
European Journal of Endocrinology 160 (5), 869-872
5 2009
High Incidence of AIP mutations in sporadic pituitary adenomas in young patients with macroadenomas
MA Tichomirova, A Daly, A Barlier, ML Jaffrain-Réa, S Zacharieva, …
The Endocrine Society’s 91st Annual Meeting: 10-13 juin 2009, Washington
5 2009
Germline mutations of AIP gene in somatotropinomas resistant to somatostatin analogues
J Oriola, T Lucas, I Halperin, M Mora, MJ Perales, GD Soto, I Salinas, …
European Journal of Endocrinology 168 (1), 9-13
4 2013
Hypopituitarism following traumatic brain injury: determining factors for diagnosis
E Fernandez-Rodriguez, I Bernabeu, AI Castro, F Kelestimur, …
Frontiers in endocrinology 2
4 2011
Hormone Use and Abuse by Athletes
Springer
4 2010
Cabergoline treatment in acromegaly: pros
M Marazuela, A Ramos-Leví, M Sampedro-Núñez, I Bernabeu
Endocrine, 1-5
3 2014
Metabolic syndrome associated with hyperprolactinemia: A new indication for dopamine agonist treatment?
I Bernabeu, FF Casanueva
Endocrine 44 (2), 273-274
3 2013
El año 2011 en Neuroendocrinología
M Puig Domingo, J Castaño, E Resmini, E Venegas, J García Arnés, …
Endocrinología y Nutrición
2 2012
Thyroid-type solid cell nests in struma ovarii
J Cameselle-Teijeiro, N Caramés, A Romero-Rojas, R Reyes-Santías, …
International journal of surgical pathology 19 (5), 627-631
2 2011
Tratamiento farmacológico de los tumores neuroendocrinos gastroenteropancreáticos: análogos de somatostatina
M Marazuela Azpíroz, E Ignacio Bernabeu Morón
Endocrinología y Nutrición 54, 44-50
2 2007
Characteristics of the Spanish version of the quality of life questionnaire (QLSM-H) in adult subjects with growth hormone deficiency treated with somatotropin: pilot study
IJ Bernabeu, S Gaztambide, E Menendez, SM Webb, A Garcia-Patterson, …
Endocrinología y nutrición 49 (4), 105-112
2 2002
Lanreotide autogel‐induced tumour shrinkage in thyrotropin‐secreting pituitary macroadenomas
AE Paniagua, I Bernabeu, S Leskela, M Marazuela
Clinical endocrinology 74 (3), 406-408
1 2011
[Thyrotropin-producing adenoma of the hypophysis]
R Araujo, J Estrada, S Díez, I Bernabeu, CP Salto
Medicina clinica 93 (15), 578-580
1 1989
[Description of Wolfram syndrome (DIDMOAD) on the basis of a new case]
MI Bernabeau, GR Cámara, AR Araujo, AS Díez, GJ Estrada, MT Lucas, …
Revista clinica espanola 184 (8), 418-420
1 1989
Update on prognostic factors in acromegaly: Is a risk score possible?
E Fernandez-Rodriguez, FF Casanueva, I Bernabeu
Pituitary, 1-10
2014
Influence of the exon 3 deletion of GH receptor and IGF-I level at diagnosis on the efficacy and safety of treatment with somatotropin in adults with GH deficiency
P Andujar-Plata, E Fernandez-Rodriguez, C Quinteiro, FF Casanueva, …
Pituitary, 1-7
2014
Escape and lipodystrophy in acromegaly during pegvisomant therapy, a retrospective multicentre Spanish study
G Sesmilo, E Resmini, I Bernabeu, J Aller, A Soto, M Mora, A Picó, …
Clinical endocrinology
2014
Consensus document of the Neuroendocrinology area of the Spanish Society of Endocrinology and Nutrition on management of hypopituitarism during transition
C Álvarez-Escolá, E Fernández-Rodríguez, JM Recio-Córdova, …
Endocrinología y Nutrición (English Edition) 61 (2), 68. e1-68. e11
2014
Documento de consenso del área de conocimiento de Neuroendocrinología de la Sociedad Española de Endocrinología y Nutrición para el abordaje del hipopituitarismo durante la transición
C Álvarez-Escolá, E Fernández-Rodríguez, JM Recio-Córdova, …
Endocrinología y Nutrición 61 (2), 68. e1-68. e11
2014
Adrenal carcinoma: a retrospective analysis of our series.
P Andujar, JM Cameselle-Teijeiro, F Barón-Duarte, I Bernabeu, …
Endocrinologia y nutricion: organo de la Sociedad Espanola de Endocrinologia …
2013
Prevalence of escape and lipodystrophy in patients treated with Pegvisomant. A multicenter study
G Sesmilo, E Resmini, I Bernabeu, J Aller, A Soto, M Marazuela, M Mora, …
BioScientifica
2013
Spanish molecular registry of pituitary adenomas: a multicenter, translational approach aimed at improving patient management
A Leal-Cerro, RM Luque, L Sanchez-Tejada, A Ibanez-Costa, M Jorda, …
BioScientifica
2013
Evaluation of the efficacy of midnight salivary cortisol plus dexamethasone suppression test as screening for the diagnosis of hypercortisolism within an at-risk population
A Leal-Cerro, A Madrazo-Atutxa, J Garcia-Arnes, C Lamas-Oliveira, …
BioScientifica
2013
Efficacy and safety of lanreotide in combination with pegvisomant in clinical practice in patients with active acromegaly with monotherapy failure
E Venegas, T Lucas, M Marazuela, G Cuatrecasas, MA Galvez, E Romero, …
BioScientifica
2013
Efficacy and safety of lanreotide in combination with cabergoline in clinical practice in patients with active acromegaly with monotherapy failure
R Vilchez, I Bernabeu, C Blanco, F Cordido, M Paja, R Casany, C Fajardo, …
BioScientifica
2013
Documento de consenso del área de conocimiento de Neuroendocrinología de la Sociedad Espanola de Endocrinología y Nutrición para el abordaje del hipopituitarismo durante la transición
JM Recio-Córdova, I Bernabéu-Morón
2013
Protocolo diagnóstico y terapéutico de las hipofisitis
E Fernández-Rodríguez, I Bernabeu, FF Casanueva
Medicine-Programa de Formación Médica Continuada acreditado 11 (13), 800-803
2012
Diagnóstico y tratamiento del incidentaloma hipofisario
P Andújar, E Fernández-Rodríguez, I Bernabeu, FF Casanueva
Medicine-Programa de Formación Médica Continuada acreditado 11 (13), 792-795
2012
Adenomas hipofisarios no funcionantes
P Andújar, E Fernández-Rodríguez, I Bernabeu, FF Casanueva
Medicine-Programa de Formación Médica Continuada acreditado 11 (13), 757-763
2012
Protocolo de diagnóstico y tratamiento de la hiperprolactinemia
E Fernández-Rodríguez, I Bernabeu, FF Casanueva
Medicine-Programa de Formación Médica Continuada acreditado 11 (13), 796-799
2012
Indicaciones y secuencia de empleo de las pruebas funcionales hipofisarias. Criterios de valoración
P Andújar, E Fernández-Rodríguez, I Bernabeu, FF Casanueva
Medicine-Programa de Formación Médica Continuada acreditado 11 (13), 788-791
2012
Enfermedades de la neurohipófisis
E Fernández-Rodríguez, I Bernabeu, FF Casanueva
Medicine-Programa de Formación Médica Continuada acreditado 11 (13), 782-787
2012
Adenomas hipofisarios funcionantes
E Fernández-Rodríguez, I Bernabeu, FF Casanueva
Medicine-Programa de Formación Médica Continuada acreditado 11 (13), 764-772
2012
Mujer de 32 años con antecedentes de migraña que consulta por galactorrea bilateral y oligomenorrea
E Fernández-Rodríguez, P Andújar, I Bernabéu, FF Casanueva
Medicine-Programa de Formación Médica Continuada acreditado 11 (13), 804. e1 …
2012
Patología del eje hipotálamo-hipofisario. Tumores pineales
P Andújar, E Fernández-Rodríguez, I Bernabeu, FF Casanueva
Medicine-Programa de Formación Médica Continuada acreditado 11 (13), 751-756
2012
Hipopituitarismo. Panhipopituitarismo
E Fernández-Rodríguez, I Bernabeu, FF Casanueva
Medicine-Programa de Formación Médica Continuada acreditado 11 (13), 773-781
2012
Mortality and survival in a large series of adult patients with hypopituitarism followed for 10 years
E Fernandez-Rodriguez, M Lopez-Raton, C Cadarso, F Casanueva, …
BioScientifica
2012
Estudio clínico y molecular de cinco familias con resistencia a la acción de las hormonas tiroideas
J Lado Abeal, R Albero Gamboa, D Araujo Vilar, O Barca Mallo, …
Medicina Clínica 137 (12), 551-554
2011
Prevalence of germline mutations of AIP gene in sporadic aggressive somatotropinomas
M Puig-Domingo, J Oriola, I Halperin, M Mora, G Diaz-Soto, MJ Perales, …
BioScientifica
2011
GH/IGF-I Axis in Exercise
E Gabellieri, I Bernabeu, E Fernandez, M Marazuela, L Chiovato, …
Hormone Use and Abuse by Athletes, 1-7
2011
General concepts of hypothalamus-pituitary anatomy
I Bernabeu, M Marazuela, FF Casanueva
Oxford Textbook of Endocrinology and Diabetes (2 ed.) 2011
2011
Nell’acromegalia la delezione dell’esone 3 del recettore del GH si associa a una migliore risposta alla terapia con pegvisomant
I Bernabeu, C Quinteiro, T Lucas, M Puig-Domingo, M Luque-Ramírez, …
L’Endocrinologo 11 (5), 231-232
2010
Lanreotide-ATG effectiveness on tumoral mass shrinkage of two thyrotropin-secreting pituitary macroadenomas
A Paniagua, I Bernabeu, M Marazuela
BioScientifica
2010
Efficacy and safety of co-administration of lanreotide Autogel 120 mg monthly with pegvisomant weekly in patients with acromegaly partially controlled by somatostatin analogues
AJ van der Lely, I Bernabeu, J Cap, P Caron, A Colao, C Lesage, J Marek, …
BioScientifica
2010
Cholestatic hepatitis with jaundice in a patient with Gilbert’s syndrome: case report
I Bernabeu
Reactions 1257, 20
2009
Actualización del tratamiento con radioyodo: utilidad de la TSH humana recombinante
A Ruibal Morell, V Pubul-Núñez, I Bernabéu Morón
Endocrinología y nutrición: órgano de la Sociedad Española de Endocrinología …
2005
Protocolo diagnóstico de la hipo e hiperfosfatemia
I Bernabéu Morón
Medicine-Programa de Formación Médica Continuada Acreditado 9 (17), 1083-1085
2004
Hipofosfatemia e hiperfosfatemia: concepto, fisiopatología, etiopatogenia, clínica, diagnóstico y tratamiento
I Bernabéu Morón
Medicine 9 (17), 1063-1069
2004
THYROTROPIN PRODUCING PITUITARY-ADENOMA
R ARAUJO, J ESTRADA, S DIEZ, I BERNABEU, C PARAMO, L SALTO
MEDICINA CLINICA 93 (15), 578-580
1989
Epidemiologic Features and Predictors of Mortality in a Cohort of Adult Patients with Hypopituitarism
E Fernandez-Rodriguez, I Bernabeu, FF Casanueva
Signs and Symptoms of Pituitary Disease
E Fernandez‐Rodriguez, I Bernabeu, FF Casanueva, EN Kassi, …
Pituitary Disorders: Diagnosis and Management, 13-20

Volver al cuadro médico

Uso de cookies

Este sitio web utiliza cookies a partir de un perfil elaborado en base a su navegación. Puede aceptar todas las cookies haciendo clic en el botón "Aceptar y seguir navegando".

Haga clic aquí para tener más información y para saber cómo configurar o rechazar su uso en "nuestra política de cookies"

Aceptar y seguir navegando
Aviso de cookies